Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Germany”
Sponsor: Gilead Sciences
Triple Negative Breast Cancer
United States, Australia, Belgium, Brazil, France +6 more
Sponsor: Takeda
Psoriatic Arthritis
United States, Argentina, Australia, Brazil, Canada +7 more
Sponsor: Novartis Pharmaceuticals
Geographic Atrophy Secondary to Age-related Macular Degeneration
United States, Australia, Bulgaria, Canada, Colombia +11 more
Sponsor: University of Hamburg-Eppendorf
Blood Pressure
Germany
Sponsor: OncoZenge AB
Head & Neck Cancer · Oral Mucositis
Denmark, Germany, Norway, Sweden
Sponsor: Celgene
Relapsed or Refractory Multiple Myeloma
United States, Argentina, Australia, Austria, Belgium +24 more
- A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic SclerosisRecruiting
Sponsor: Novartis Pharmaceuticals
Diffuse Cutaneous Systemic Sclerosis
United States, Argentina, Austria, Belgium, Brazil +20 more
Sponsor: AstraZeneca
Type 2 Diabetes Mellitus
United States, Argentina, Australia, Brazil, Bulgaria +10 more
Sponsor: Stephanie Mehl
Delusional Disorder · Brief Psychotic Disorder · Schizophreniform Disorder · Schizophrenia / Schizoaffective Disorder
Germany
- Phase IIa Study Evaluating AZD7798 in Crohn's DiseaseActive Not Recruiting
Sponsor: AstraZeneca
Moderate to Severe Crohn's Disease
United States, Argentina, Australia, Belgium, Brazil +21 more
Sponsor: AbbVie
Plaque Psoriasis
Canada, Czechia, France, Germany, Greece +3 more
Sponsor: Novartis Pharmaceuticals
Still´s Disease
United States, Canada, France, Germany, Italy +3 more
Sponsor: AstraZeneca
Chronic Kidney Disease
United States, Argentina, Australia, Brazil, Bulgaria +32 more
- ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart AttackActive Not Recruiting
Sponsor: Novo Nordisk A/S
Cardiovascular Risk · Acute Myocardial Infarction (AMI)
United States, Argentina, Australia, Brazil, Bulgaria +19 more
Sponsor: Swedish Orphan Biovitrum
C3 Glomerulopathy (C3G) · Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
Australia, Austria, Belgium, Canada, Czechia +9 more
- A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDACActive Not Recruiting
Sponsor: Genentech, Inc.
Adenocarcinoma, Pancreatic Ductal
United States, Belgium, Canada, France, Germany +5 more
Sponsor: Merck Sharp & Dohme LLC
Radiographic Axial Spondyloarthritis
United States, Brazil, Canada, Chile, China +9 more
Sponsor: Novartis Pharmaceuticals
Early Breast Cancer
United States, Argentina, Australia, Brazil, Canada +11 more
- A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung CancerActive Not Recruiting
Sponsor: Hoffmann-La Roche
Small-Cell Lung Cancer
United States, Belgium, Germany, Greece, Hungary +8 more
Sponsor: University Medical Center Goettingen
Oral Health Care · Oral Health Behavior Change · Head & Neck Cancer · Dentist's Role
Germany
Sponsor: Hoffmann-La Roche
Hemophilia A
United States, Argentina, Brazil, Denmark, France +10 more
Sponsor: Novo Nordisk A/S
Diabetes Mellitus, Type 2
United States, Argentina, Australia, Brazil, Canada +9 more
Sponsor: AstraZeneca
Gastric Cancer · Gastroesophageal Junction Adenocarcinoma · Esophageal Cancer
United States, Australia, Austria, Belgium, Brazil +19 more
- A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With TezepelumabActive Not Recruiting
Sponsor: AstraZeneca
Chronic Rhinosinusitis With Nasal Polyps
United States, Bulgaria, Canada, France, Germany +4 more
Sponsor: Varian, a Siemens Healthineers Company
Prostate Cancer
United States, Germany, Spain